Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of chiral compounds for drug development. Its cyclopropane structure with a fluorinated aryl group enhances metabolic stability and bioavailability in active pharmaceutical ingredients. Commonly employed in the preparation of beta-blockers and other cardiovascular agents due to its ability to influence stereochemistry and binding affinity in target molecules. Also utilized in research for developing novel fluorinated analogs with improved pharmacokinetic profiles.